Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma: A Dose-Finding Study

By Reni M.   Cereda S.   Bonetto E.   Vigano M. G.   Passoni P.   Zerbi A.   Balzano G.   Nicoletti R.   Staudacher C.   Carlo V. Di  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 594-598

Informa Healthcare

Access to resources Recommend Favorite

Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

By Reni M.   Cereda S.   Bonetto E.   Viganò M.   Passoni P.   Zerbi A.   Balzano G.   Nicoletti R.   Staudacher C.   Di Carlo V.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 361-367

Springer Publishing Company

Access to resources Recommend Favorite

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapynaive advanced non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1699-1703

Spandidos Publications

Access to resources Recommend Favorite

Pilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancer

By                                          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 265-269

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer

By Cappuzzo F.   De Marinis F.   Nelli F.   Calandri C.   Maestri A.   Benedetti G.   Migliorino M.R.   Cortesi E.   Rastelli F.   Martelli O.   Andruccetti M.   Bartolini S.   Crino L.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 355-361

Elsevier

Access to resources Recommend Favorite